|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
135 a.a.
|
 |
|
|
|
|
|
|
|
112 a.a.
|
 |
|
|
|
|
|
|
|
220 a.a.
|
 |
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
DNA binding protein
|
 |
|
Title:
|
 |
Crystal structure of an ikbbeta/nf-kb p65 homodimer complex
|
|
Structure:
|
 |
Transcription factor p65. Chain: c, b. Fragment: p65 dimerization domain. Synonym: nuclear factor nf-kappa-b p65 subunit. Engineered: yes. Transcription factor inhibitor i-kappa-b-beta. Chain: d. Engineered: yes
|
|
Source:
|
 |
Mus musculus. House mouse. Organism_taxid: 10090. Gene: rela or nfkb3. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
|
|
Biol. unit:
|
 |
Trimer (from
)
|
|
Resolution:
|
 |
|
2.05Å
|
R-factor:
|
0.218
|
R-free:
|
0.247
|
|
|
Authors:
|
 |
S.Malek,D.B.Huang,T.Huxford,S.Ghosh,G.Ghosh
|
Key ref:
|
 |
S.Malek
et al.
(2003).
X-ray crystal structure of an IkappaBbeta x NF-kappaB p65 homodimer complex.
J Biol Chem,
278,
23094-23100.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
03-Apr-03
|
Release date:
|
20-May-03
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
Q04207
(TF65_MOUSE) -
Transcription factor p65
|
|
|
|
Seq: Struc:
|
 |
 |
 |
549 a.a.
135 a.a.
|
|
|
|
|
|
|
 |
 |
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
nucleus
|
1 term
|
 |
|
Biological process
|
regulation of transcription, DNA-dependent
|
1 term
|
 |
|
Biochemical function
|
transcription factor activity
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
278:23094-23100
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
X-ray crystal structure of an IkappaBbeta x NF-kappaB p65 homodimer complex.
|
|
S.Malek,
D.B.Huang,
T.Huxford,
S.Ghosh,
G.Ghosh.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
We report the crystal structure of a murine IkappaBbeta x NF-kappaB p65
homodimer complex. Crystallographic models were determined for two triclinic
crystalline systems and refined against data at 2.5 and 2.1 A. The overall
complex structure is similar to that of the IkappaBalpha.NF-kappaB p50/p65
heterodimer complex. One NF-kappaB p65 subunit nuclear localization signal
clearly contacts IkappaBbeta, whereas a homologous segment from the second
subunit of the homodimer is mostly solvent-exposed. The unique 47-amino acid
insertion between ankyrin repeats three and four of IkappaBbeta is mostly
disordered in the structure. Primary sequence analysis and differences in the
mode of binding at the IkappaBbeta sixth ankyrin repeat and NF-kappaB p65
homodimer suggest a model for nuclear IkappaBbeta.NF-kappaB.DNA ternary complex
formation. These unique structural features of IkappaBbeta may contribute to its
ability to mediate persistent NF-kappaB activation.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
FIG. 4. Comparison of the interactions between the sixth
ankyrin repeat of I B and I B and the
p65 subunit A. A, superposition of the p65 subunit A
dimerization domain from the two I B·NF- B
complexes reveals the overall similarity in position and fold of
the complex-associated I B and I B . Color
scheme is consistent with previous figures, except that the p65
subunit from the I B ·NF- B
complex structure is depicted in pink. Ankyrin repeats are
numbered. One noticeable difference (enclosed within the dashed
black box) is that the sixth ankyrin repeat of I B occupies
a position at a greater distance from p65 than does the
corresponding segment of I B . B, close up
stereoview of the boxed area from A. Arg260 and Trp258 are
labeled as reference points.
|
 |
Figure 5.
FIG. 5. To model the I B ·p65·DNA
ternary complex, atomic coordinates from the
p65·interleukin-8- B DNA complex were used
(54). The dimerization domains of p65 were superposed on to the
similar domains from the present structure. The second p65 NLS
has been removed from this model. Three arginine side chains
that are positioned near the interleukin-8 B DNA (gray cpk model)
from I B , Arg275, Arg284, and
Arg294, are rendered as ball-and-stick models.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2003,
278,
23094-23100)
copyright 2003.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Zheng,
Q.Yin,
and
H.Wu
(2011).
Structural studies of NF-κB signaling.
|
| |
Cell Res, 21,
183-195.
|
 |
|
|
|
|
 |
T.Valovka,
and
M.O.Hottiger
(2011).
p65 controls NF-κB activity by regulating cellular localization of IκBβ.
|
| |
Biochem J, 434,
253-263.
|
 |
|
|
|
|
 |
B.Manavalan,
S.Basith,
Y.M.Choi,
G.Lee,
and
S.Choi
(2010).
Structure-function relationship of cytoplasmic and nuclear IκB proteins: an in silico analysis.
|
| |
PLoS One, 5,
e15782.
|
 |
|
|
|
|
 |
C.H.Chang,
C.Y.Chen,
J.Y.Chiou,
R.Y.Peng,
and
C.H.Peng
(2010).
Astaxanthine secured apoptotic death of PC12 cells induced by beta-amyloid peptide 25-35: its molecular action targets.
|
| |
J Med Food, 13,
548-556.
|
 |
|
|
|
|
 |
H.Kamata,
Y.Tsuchiya,
and
T.Asano
(2010).
IκBβ is a positive and negative regulator of NF-κB activity during inflammation.
|
| |
Cell Res, 20,
1178-1180.
|
 |
|
|
|
|
 |
P.Rao,
M.S.Hayden,
M.Long,
M.L.Scott,
A.P.West,
D.Zhang,
A.Oeckinghaus,
C.Lynch,
A.Hoffmann,
D.Baltimore,
and
S.Ghosh
(2010).
IkappaBbeta acts to inhibit and activate gene expression during the inflammatory response.
|
| |
Nature, 466,
1115-1119.
|
 |
|
|
|
|
 |
S.Wu,
and
L.Tong
(2010).
Differential signaling circuits in regulation of ultraviolet C light-induced early- and late-phase activation of NF-κB.
|
| |
Photochem Photobiol, 86,
995-999.
|
 |
|
|
|
|
 |
A.Oeckinghaus,
and
S.Ghosh
(2009).
The NF-kappaB family of transcription factors and its regulation.
|
| |
Cold Spring Harbor Perspect Biol, 1,
a000034.
|
 |
|
|
|
|
 |
C.F.László,
and
S.Wu
(2009).
Old target new approach: an alternate NF-kappaB activation pathway via translation inhibition.
|
| |
Mol Cell Biochem, 328,
9.
|
 |
|
|
|
|
 |
C.Gasparini,
B.M.Foxwell,
and
M.Feldmann
(2009).
RelB/p50 regulates CCL19 production, but fails to promote human DC maturation.
|
| |
Eur J Immunol, 39,
2215-2223.
|
 |
|
|
|
|
 |
S.Bergqvist,
V.Alverdi,
B.Mengel,
A.Hoffmann,
G.Ghosh,
and
E.A.Komives
(2009).
Kinetic enhancement of NF-kappaBxDNA dissociation by IkappaBalpha.
|
| |
Proc Natl Acad Sci U S A, 106,
19328-19333.
|
 |
|
|
|
|
 |
T.Huxford,
and
G.Ghosh
(2009).
A structural guide to proteins of the NF-kappaB signaling module.
|
| |
Cold Spring Harbor Perspect Biol, 1,
a000075.
|
 |
|
|
|
|
 |
C.F.László,
and
S.Wu
(2008).
Mechanism of UV-induced IkappaBalpha-independent activation of NF-kappaB.
|
| |
Photochem Photobiol, 84,
1564-1568.
|
 |
|
|
|
|
 |
M.Coiras,
M.R.Lopez-Huertas,
E.Mateos,
and
J.Alcami
(2008).
Caspase-3-mediated cleavage of p65/RelA results in a carboxy-terminal fragment that inhibits IkappaBalpha and enhances HIV-1 replication in human T lymphocytes.
|
| |
Retrovirology, 5,
109.
|
 |
|
|
|
|
 |
S.C.Sue,
C.Cervantes,
E.A.Komives,
and
H.J.Dyson
(2008).
Transfer of flexibility between ankyrin repeats in IkappaB* upon formation of the NF-kappaB complex.
|
| |
J Mol Biol, 380,
917-931.
|
 |
|
|
|
|
 |
D.U.Ferreiro,
C.F.Cervantes,
S.M.Truhlar,
S.S.Cho,
P.G.Wolynes,
and
E.A.Komives
(2007).
Stabilizing IkappaBalpha by "consensus" design.
|
| |
J Mol Biol, 365,
1201-1216.
|
 |
|
|
|
|
 |
R.García-Román,
J.I.Pérez-Carreón,
A.Márquez-Quiñones,
M.E.Salcido-Neyoy,
and
S.Villa-Treviño
(2007).
Persistent activation of NF-kappaB related to IkappaB's degradation profiles during early chemical hepatocarcinogenesis.
|
| |
J Carcinog, 6,
5.
|
 |
|
|
|
|
 |
S.K.Moon,
J.I.Woo,
H.Y.Lee,
R.Park,
J.Shimada,
H.Pan,
R.Gellibolian,
and
D.J.Lim
(2007).
Toll-like receptor 2-dependent NF-kappaB activation is involved in nontypeable Haemophilus influenzae-induced monocyte chemotactic protein 1 up-regulation in the spiral ligament fibrocytes of the inner ear.
|
| |
Infect Immun, 75,
3361-3372.
|
 |
|
|
|
|
 |
A.Hoffmann,
G.Natoli,
and
G.Ghosh
(2006).
Transcriptional regulation via the NF-kappaB signaling module.
|
| |
Oncogene, 25,
6706-6716.
|
 |
|
|
|
|
 |
A.S.Chung,
Y.J.Guan,
Z.L.Yuan,
J.E.Albina,
and
Y.E.Chin
(2005).
Ankyrin repeat and SOCS box 3 (ASB3) mediates ubiquitination and degradation of tumor necrosis factor receptor II.
|
| |
Mol Cell Biol, 25,
4716-4726.
|
 |
|
|
|
|
 |
D.H.Dreyfus,
M.Nagasawa,
E.W.Gelfand,
and
L.Y.Ghoda
(2005).
Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors.
|
| |
BMC Immunol, 6,
12.
|
 |
|
|
|
|
 |
E.Hertlein,
J.Wang,
K.J.Ladner,
N.Bakkar,
and
D.C.Guttridge
(2005).
RelA/p65 regulation of IkappaBbeta.
|
| |
Mol Cell Biol, 25,
4956-4968.
|
 |
|
|
|
|
 |
H.C.Chang,
K.Tan,
J.Ouyang,
E.Parisini,
J.H.Liu,
Y.Le,
X.Wang,
E.L.Reinherz,
and
J.H.Wang
(2005).
Structural and mutational analyses of a CD8alphabeta heterodimer and comparison with the CD8alphaalpha homodimer.
|
| |
Immunity, 23,
661-671.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.K.Mosavi,
T.J.Cammett,
D.C.Desrosiers,
and
Z.Y.Peng
(2004).
The ankyrin repeat as molecular architecture for protein recognition.
|
| |
Protein Sci, 13,
1435-1448.
|
 |
|
|
|
|
 |
S.O'Connor,
S.D.Shumway,
I.J.Amanna,
C.E.Hayes,
and
S.Miyamoto
(2004).
Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells.
|
| |
Mol Cell Biol, 24,
4895-4908.
|
 |
|
|
|
|
 |
S.Zelivianski,
R.Glowacki,
and
M.F.Lin
(2004).
Transcriptional activation of the human prostatic acid phosphatase gene by NF-kappaB via a novel hexanucleotide-binding site.
|
| |
Nucleic Acids Res, 32,
3566-3580.
|
 |
|
|
|
|
 |
X.Lu,
P.Farmer,
J.Rubin,
and
M.S.Nanes
(2004).
Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
|
| |
J Cell Biochem, 92,
833-848.
|
 |
|
|
|
|
 |
Y.Chen,
S.Vallee,
J.Wu,
D.Vu,
J.Sondek,
and
G.Ghosh
(2004).
Inhibition of NF-kappaB activity by IkappaBbeta in association with kappaB-Ras.
|
| |
Mol Cell Biol, 24,
3048-3056.
|
 |
|
|
|
|
 |
C.Schmidt,
B.Peng,
Z.Li,
G.M.Sclabas,
S.Fujioka,
J.Niu,
M.Schmidt-Supprian,
D.B.Evans,
J.L.Abbruzzese,
and
P.J.Chiao
(2003).
Mechanisms of proinflammatory cytokine-induced biphasic NF-kappaB activation.
|
| |
Mol Cell, 12,
1287-1300.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
| |